Activation of cytosolic phospholipase A2 in human T-lymphocytes involves inhibitor-κB and mitogen-activated protein kinases

被引:7
作者
Burgermeister, E
Endl, J
Scheuer, WV
机构
[1] Roche Diagnost GmbH, Dept Mol Pharmacol, D-82377 Penzberg, Germany
[2] Weizmann Inst Sci, Dept Regulat Biol, I-76100 Rehovot, Israel
[3] Roche Diagnost GmbH, Dept Cell Biol, D-82377 Penzberg, Germany
关键词
phospholipase A(2); NF kappa B (nuclear factor-kappa B); MAP (mitogen-activated protein) kinase; interleukin-2; T-lymphocyte;
D O I
10.1016/S0014-2999(03)01492-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The group IV 85 kDa cytosolic phospholipase A(2) regulates many aspects of innate immunity. However, the function of this enzyme in T-cells remains controversial. We show here that human peripheral blood lymphocytes and Jurkat cells express cytosolic phospholipase A(2) and produce prostaglandin A(2) and leukotriene B-4. Selective inhibitors of this enzyme suppressed Ca2+-ionophore-, mitogen- and T-cell receptor-mediated expression of interleukin-2 at the level of transcription from the promoter. Activation of mitogen-activated protein kinases (MAPK), degradation of inhibitor-kappaBalpha and transactivation by nuclear factor-kappaB (NFkappaB) were impaired as was the antigen-, lectin- and interleukin-2-driven proliferation of T-cells in vitro. Ligands of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) induced rapid phosphorylation of MAPK in human monocytic but not in Jurkat cells. These data indicated that in T-cells, eicosanoids generated upon signal-activated cytosolic phospholipase A2 promote NFkappaB-dependent interleukin-2 transcription via a PPAR-gamma-independent mechanism involving the MAPK-pathway. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:169 / 180
页数:12
相关论文
共 51 条
[1]   Arachidonic acid directly activates members of the mitogen-activated protein kinase superfamily in rabbit proximal tubule cells [J].
Alexander, LD ;
Cui, XL ;
Falck, JR ;
Douglas, JG .
KIDNEY INTERNATIONAL, 2001, 59 (06) :2039-2053
[2]   Suppression of cytokine synthesis, integrin expression and chronic inflammation by inhibitors of cytosolic phospholipase A(2) [J].
AmandiBurgermeister, E ;
Tibes, U ;
Kaiser, BM ;
Friebe, WG ;
Scheuer, WV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 326 (2-3) :237-250
[3]   Atypical λ/ιPKC conveys 5-lipoxygenase-leukotriene B4-mediated cross-talk between phospholipase A2s regulating NF-κB activation in response to tumor necrosis factor-α and interleukin-1β [J].
Anthonsen, MW ;
Andersen, S ;
Solhaug, A ;
Johansen, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) :35344-35351
[4]   Anti-CD3 and concanavalin A-induced human T cell proliferation is associated with an increased rate of arachidonate-phospholipid remodeling -: Lack of involvement of group IV and group VI phospholipase A2 in remodeling and increased susceptibility of proliferating T cells to CoA-independent transacylase inhibitor-induced apoptosis [J].
Boilard, E ;
Surette, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :17568-17575
[5]   Arachidonic acid as a bioactive molecule [J].
Brash, AR .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (11) :1339-1345
[6]   Prostanoid receptors: Subtypes and signaling [J].
Breyer, RM ;
Bagdassarian, CK ;
Myers, SA ;
Breyer, MD .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :661-690
[7]   Activation of nuclear factor-κB by lipopolysaccharide in mononuclear leukocytes is prevented by inhibitors of cytosolic phospholipase A2 [J].
Burgermeister, E ;
Tibes, U ;
Stockinger, H ;
Scheuer, WV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 369 (03) :373-386
[8]   Inhibition of cytosolic phospholipase A2 attenuates activation of mitogen-activated protein kinases in human monocytic cells [J].
Burgermeister, E ;
Pessara, U ;
Tibes, U ;
Küster, A ;
Heinrich, PC ;
Scheuer, WV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 388 (03) :195-208
[9]   Mammalian phospholipases A2:: mediators of inflammation, proliferation and apoptosis [J].
Capper, EA ;
Marshall, LA .
PROGRESS IN LIPID RESEARCH, 2001, 40 (03) :167-197
[10]  
Chang LC, 2001, J LEUKOCYTE BIOL, V69, P659